Clinical Trial Update: Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)

View source ↗

Summary

Post-market observation study PROVIDE evaluating intra-renal drug delivery by Angiodynamics has been terminated; the record notes the trial ended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Injury

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Acute Kidney Injury, Acute Renal Failure | Status: TERMINATED